Compounds > fullerene c60
Page last updated: 2024-09-03

fullerene c60 and transforming growth factor beta

fullerene c60 has been researched along with transforming growth factor beta in 3 studies

Compound Research Comparison

Studies
(fullerene c60)		Trials
(fullerene c60)		Recent Studies (post-2010)
(fullerene c60)		Studies
(transforming growth factor beta)		Trials
(transforming growth factor beta)		Recent Studies (post-2010) (transforming growth factor beta)
3,80652,17049,11956017,610

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chou, CK; Huang, YL; Hwang, KC; Luh, TY; Shen, CK; Yang, HC1
Da Ros, T; Gerdol, M; Lucafò, M; Pacor, S; Pallavicini, A; Prato, M; Sava, G; Zorzet, S1
Bai, R; Chen, C; Chen, Z; Dong, J; Gao, X; Li, H; Liu, S; Liu, Y; Lobie, PE; Lu, X; Qian, P; Sun, B; Tang, J; Wang, L; Wicha, MS; Wu, Q; Zhang, H; Zhang, W; Zhang, X; Zhao, F; Zhao, Y; Zhu, T1

Other Studies

3 other study(ies) available for fullerene c60 and transforming growth factor beta

ArticleYear
Blockage of apoptotic signaling of transforming growth factor-beta in human hepatoma cells by carboxyfullerene.
    European journal of biochemistry, 1998, May-15, Volume: 254, Issue:1

    Topics: Acetylcysteine; Apoptosis; Ascorbic Acid; Carbon; Carboxylic Acids; Carcinoma, Hepatocellular; Cell Survival; Flow Cytometry; Fluorescent Dyes; Free Radical Scavengers; Fullerenes; Humans; Liposomes; Molecular Structure; Plasminogen Activator Inhibitor 1; Promoter Regions, Genetic; Reactive Oxygen Species; Signal Transduction; Stereoisomerism; Transforming Growth Factor beta; Tumor Cells, Cultured

1998
Profiling the molecular mechanism of fullerene cytotoxicity on tumor cells by RNA-seq.
    Toxicology, 2013, Dec-06, Volume: 314, Issue:1

    Topics: Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; DNA; Down-Regulation; Drug Screening Assays, Antitumor; Extracellular Matrix; Fullerenes; Gene Expression; Humans; Nanostructures; Neoplasm Proteins; Resting Phase, Cell Cycle; RNA; Sequence Analysis, RNA; Signal Transduction; TOR Serine-Threonine Kinases; Transcriptome; Transforming Growth Factor beta; Up-Regulation

2013
Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor.
    Nature communications, 2015, Jan-23, Volume: 6

    Topics: Animals; Apoptosis; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; Epithelial-Mesenchymal Transition; Female; Fullerenes; Gadolinium; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanomedicine; Nanostructures; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Neoplastic Stem Cells; Transforming Growth Factor beta; Triple Negative Breast Neoplasms

2015